儿童回结肠套肠套叠复位中的镇静与镇痛
该横断面研究纳入14国86家儿科三级机构、2017年1月至2019年12月、4至48月龄回结肠套叠复位患儿3203例(中位年龄17月,男64.1%)。阿片类镇痛12.6%、镇静10.6%、两者联用5.7%;肠穿孔0.4%。校正分析中,阿片类及镇静与穿孔、复位失败均无显著关联;仅更小年龄、更短症状时长和胃肠道异常与复位失败显著相关。作者认为这挑战了复位时常规不给镇痛镇静的做法。
要点
- 3203例回结肠套叠复位患儿中,镇痛12.6%、镇静10.6%、两者联用5.7%,超过三分之二未接受任何镇痛或镇静。
- 肠穿孔仅0.4%(13/3203);校正分析中,阿片类联用镇静与穿孔无显著关联(未校正OR 5.92,95%CI 1.28-27.42,P=0.02)。
- 复位成功率84.8%(2700/3184);校正后仅更小年龄(OR 1.05/月,95%CI 1.03-1.06,P<0.001)、更短症状时长(OR 0.96/小时,95%CI 0.94-0.99,P=0.002)和胃肠道异常(OR 6.50,95%CI 2.04-20.64,P=0.002)与失败显著相关。
- 作者认为,镇痛镇静与穿孔或复位失败无关,挑战了复位时普遍不给镇痛镇静的临床做法。
适用人群与场景
- 4至48月龄、尝试回结肠套叠复位的患儿,来自14国86家儿科三级机构,2017年1月至2019年12月。
研究设计与关键结果
- 研究类型:横断面研究,回顾86家儿科三级机构医疗记录;3555份符合条件记录中排除352份,最终纳入3203例;中位年龄17月(IQR 9-27),男64.1%(2054/3203)。
- 阿片类镇痛(基于IV吗啡治疗窗,定义为复位前120分钟内)12.6%(395/3134),镇静(复位前即刻)10.6%(334/3161),两者联用5.7%(178/3134);肠穿孔0.4%(13/3203)。
- 未校正分析:阿片类联用镇静(OR 5.92,95%CI 1.28-27.42,P=0.02)和更多复位次数(OR 1.48,95%CI 1.03-2.11,P=0.03)与穿孔显著相关;校正后两者均不显著。
- 复位成功84.8%(2700/3184);未校正分析中,更小年龄、分诊时未评估疼痛、阿片类、更长症状时长、水压灌肠和胃肠道异常与复位失败显著相关;校正后仅更小年龄(OR 1.05/月,95%CI 1.03-1.06,P<0.001)、更短症状时长(OR 0.96/小时,95%CI 0.94-0.99,P=0.002)和胃肠道异常(OR 6.50,95%CI 2.04-20.64,P=0.002)仍显著。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该研究结果挑战了儿童回结肠套叠复位时普遍不给镇痛镇静的广泛做法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Ileocolic intussusception is an important cause of intestinal obstruction in children. Reduction of ileocolic intussusception using air or fluid enema is the standard of care. This likely distressing procedure is usually performed without sedation or analgesia, but practice variation exists.
OBJECTIVE: To characterize the prevalence of opioid analgesia and sedation and assess their association with intestinal perforation and failed reduction.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study reviewed medical records of children aged 4 to 48 months with attempted reduction of ileocolic intussusception at 86 pediatric tertiary care institutions in 14 countries from January 2017 to December 2019. Of 3555 eligible medical records, 352 were excluded, and 3203 medical records were eligible. Data were analyzed in August 2022.
EXPOSURES: Reduction of ileocolic intussusception.
MAIN OUTCOMES AND MEASURES: The primary outcomes were opioid analgesia within 120 minutes of reduction based on the therapeutic window of IV morphine and sedation immediately before reduction of intussusception.
RESULTS: We included 3203 patients (median [IQR] age, 17 [9-27] months; 2054 of 3203 [64.1%] males). Opioid use was documented in 395 of 3134 patients (12.6%), sedation 334 of 3161 patients (10.6%), and opioids plus sedation in 178 of 3134 patients (5.7%). Perforation was uncommon and occurred in 13 of 3203 patients (0.4%). In the unadjusted analysis, opioids plus sedation (odds ratio [OR], 5.92; 95% CI, 1.28-27.42; P = .02) and a greater number of reduction attempts (OR, 1.48; 95% CI, 1.03-2.11; P = .03) were significantly associated with perforation. In the adjusted analysis, neither of these covariates remained significant. Reductions were successful in 2700 of 3184 attempts (84.8%). In the unadjusted analysis, younger age, no pain assessment at triage, opioids, longer duration of symptoms, hydrostatic enema, and gastrointestinal anomaly were significantly associated with failed reduction. In the adjusted analysis, only younger age (OR, 1.05 per month; 95% CI, 1.03-1.06 per month; P < .001), shorter duration of symptoms (OR, 0.96 per hour; 95% CI, 0.94-0.99 per hour; P = .002), and gastrointestinal anomaly (OR, 6.50; 95% CI, 2.04-20.64; P = .002) remained significant.
CONCLUSIONS AND RELEVANCE: This cross-sectional study of pediatric ileocolic intussusception found that more than two-thirds of patients received neither analgesia nor sedation. Neither was associated with intestinal perforation or failed reduction, challenging the widespread practice of withholding analgesia and sedation for reduction of ileocolic intussusception in children.
参考来源
- Poonai N, Cohen DM, MacDowell D, et al. Sedation and Analgesia for Reduction of Pediatric Ileocolic Intussusception. JAMA Netw Open. 2023. PMID: 37285152. doi:10.1001/jamanetworkopen.2023.17200
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。